Bile-Salt Micelles and Solubilization Capacity

Why Bile-Salt Micelles Add Solubilization Capacity

A poorly water-soluble drug can have a low freely dissolved equilibrium concentration while still being carried at a higher total concentration in intestinal fluid. Bile salts can self-associate into micelles: aggregates with regions that accommodate drug molecules that are unfavorable in water. The key distinction is between free drug, dissolved in the aqueous phase, and micelle-associated drug. The latter contributes to measured total dissolved drug but is not the same as free-drug concentration.

This tutorial develops a deliberately simple capacity calculation for bile salts alone. It estimates how much micelle-associated drug can accompany the freely dissolved concentration at equilibrium. The calculation is useful for understanding the scale of a solubilization contribution; it is not a prediction of intestinal absorption or a complete description of the composition of intestinal fluids.

Definition: The critical micelle concentration (CMC) is an effective concentration threshold above which an amphiphile forms appreciable micellar aggregates. In the simplified threshold model, if total bile-salt concentration is \(C_{\mathrm{BS}}\) and the effective CMC is \(C_{\mathrm{CMC}}\), the micellized bile-salt concentration is \(C_{\mathrm{mic}}=\max(C_{\mathrm{BS}}-C_{\mathrm{CMC}},0)\). The CMC and both concentrations must use the same units.

The threshold model treats bile salt below the CMC as monomeric and assumes that, above it, the monomer concentration remains approximately at the CMC while additional bile salt contributes to micelles. This is an approximation: aggregation may occur over a concentration range, and the effective threshold depends on conditions such as bile-salt composition, ionic strength, pH, and temperature. For a calculation, the CMC should therefore be an appropriate measured or specified value, not a universal constant.

A Capacity Model for Free and Micelle-Associated Drug

Let \(C_{\mathrm{free}}\) denote the concentration of free dissolved drug, \(C_{\mathrm{bound}}\) the concentration of drug associated with micelles, and \(C_{\mathrm{diss}}\) the total dissolved drug concentration. Concentrations of drug may be expressed on a molar or mass basis, but all drug concentrations in a given equation must use the same basis. A simple linear partition approximation is

C_{\mathrm{bound}}=\beta C_{\mathrm{mic}}C_{\mathrm{free}}, \qquad C_{\mathrm{diss}}=C_{\mathrm{free}}+C_{\mathrm{bound}} =C_{\mathrm{free}}\left(1+\beta C_{\mathrm{mic}}\right).

Here \(\beta\) is a concentration-based micellar binding coefficient with units reciprocal to the concentration units used for \(C_{\mathrm{mic}}\). For example, if \(C_{\mathrm{mic}}\) is in mol/L, \(\beta\) has units L/mol. The product \(\beta C_{\mathrm{mic}}\) is dimensionless. This model assumes a constant proportionality between free drug and micelle-associated drug at a given micellar concentration. It does not explicitly represent a finite number of binding sites or a changing micellar composition.

If solid drug remains present and equilibrium with that solid is reached, the free concentration is \(C_{\mathrm{free}}=S_0\), where \(S_0\) is the drug's freely dissolved equilibrium solubility under the specified aqueous conditions. The saturated dissolved concentration predicted by this model is therefore

C_{\mathrm{diss,sat}}=S_0\left(1+\beta C_{\mathrm{mic}}\right), \qquad C_{\mathrm{bound,sat}}=S_0\beta C_{\mathrm{mic}}.

The additional capacity beyond the free-drug concentration is \(C_{\mathrm{bound,sat}}\), not the full value \(C_{\mathrm{diss,sat}}\). This distinction matters: the micelles raise the amount of drug that can be present in the dissolved pool without changing the definition of free-drug equilibrium solubility.

Definition: At free-drug saturation, the micellar solubilization increment is \(C_{\mathrm{bound,sat}}=S_0\beta C_{\mathrm{mic}}\). The total saturated dissolved concentration is the sum of free and micelle-associated drug, \(S_0+C_{\mathrm{bound,sat}}\). These expressions describe a capacity only if sufficient drug is available to reach saturation.

A related way to express capacity is the molar solubilization ratio \(q\): the moles of drug associated with micelles per mole of micellized bile salt at saturation. When \(S_0\) and drug concentrations are expressed in mol/L, the linear model gives \(q=\beta S_0\), a dimensionless ratio. Thus \(C_{\mathrm{bound,sat}}=qC_{\mathrm{mic}}\). This form is convenient when experimental data report added drug per amount of micellized bile salt; the \(\beta\) form is convenient when capacity is described relative to free-drug concentration.

Deriving the Saturated Capacity

The saturated result follows directly from two assumptions: free drug is at equilibrium with excess solid, and micelle-associated drug is proportional to both free drug and micellar concentration. First, solid–solution equilibrium sets the free concentration to \(S_0\). Substitution into the partition relationship gives the amount associated with micelles. Adding the two dissolved pools gives the total:

Set the free concentration.
With excess solid present at equilibrium, \(C_{\mathrm{free}}=S_0\).

Calculate the micelle-associated pool.
Substituting into the linear relationship gives \(C_{\mathrm{bound}}=\beta C_{\mathrm{mic}}S_0\).

Sum the dissolved pools.
\(C_{\mathrm{diss}}=S_0+\beta C_{\mathrm{mic}}S_0=S_0(1+\beta C_{\mathrm{mic}})\).

This is a capacity calculation, not a guarantee that the system reaches that concentration. If the administered amount is too small to supply the calculated amount, or if equilibrium is not reached, the actual dissolved concentration will be lower. The solid-present condition is also important: without excess solid, the free concentration need not equal \(S_0\).

Worked Example: Calculating Capacity From a Binding Coefficient

Consider a hypothetical aqueous system with total bile-salt concentration \(12.0\) mmol/L, an effective CMC of \(4.0\) mmol/L, freely dissolved equilibrium drug solubility \(S_0=0.020\) mg/mL, and \(\beta=25.0\) L/mol. Assume excess solid drug remains, the linear model applies, and the stated CMC is appropriate for the conditions.

First calculate the micellized bile-salt concentration:

C_{\mathrm{mic}}=12.0-4.0=8.0\ \mathrm{mmol/L} =0.0080\ \mathrm{mol/L}.

The dimensionless binding multiplier is \(\beta C_{\mathrm{mic}}=(25.0\ \mathrm{L/mol})(0.0080\ \mathrm{mol/L})=0.200\). Therefore the micelle-associated drug concentration at saturation is

C_{\mathrm{bound,sat}}=(0.020\ \mathrm{mg/mL})(0.200) =0.0040\ \mathrm{mg/mL}.

The total saturated dissolved concentration is \(0.020+0.0040=0.0240\) mg/mL. In this hypothetical example, micelles add \(0.0040\) mg/mL beyond the free-drug equilibrium concentration. They do not make the free concentration \(0.0240\) mg/mL; at saturation it remains \(0.020\) mg/mL under the model assumptions.

Worked Capacity Calculations

Worked Example: Using a Molar Solubilization Ratio

In a hypothetical system, total bile-salt concentration is \(15.0\) mmol/L, the effective CMC is \(3.0\) mmol/L, the molar solubilization ratio is \(q=0.0350\) mol drug per mol micellized bile salt, and free-drug solubility is \(0.080\) mmol/L. The solution volume is \(0.250\) L, and at least \(0.200\) mmol of drug is available, so the saturated capacity can be reached if equilibrium is attained.

The micellized bile-salt concentration is \(15.0-3.0=12.0\) mmol/L. The saturated micelle-associated drug concentration is

C_{\mathrm{bound,sat}}=qC_{\mathrm{mic}} =(0.0350)(12.0\ \mathrm{mmol/L}) =0.420\ \mathrm{mmol/L}.

Adding the free pool gives \(C_{\mathrm{diss,sat}}=0.080+0.420=0.500\) mmol/L. In \(0.250\) L, the saturated dissolved amount is \((0.500\ \mathrm{mmol/L})(0.250\ \mathrm{L})=0.125\) mmol. Of this, \((0.080)(0.250)=0.0200\) mmol is free and \((0.420)(0.250)=0.105\) mmol is micelle-associated. Since \(0.200\) mmol is available, there is enough drug to supply the \(0.125\) mmol dissolved capacity, with solid remaining under the stated assumptions.

Worked Example: Comparing Bile-Salt Concentrations Below and Above the CMC

Suppose a hypothetical drug has \(S_0=0.050\) mg/mL and \(\beta=40.0\) L/mol. The effective CMC is \(3.0\) mmol/L. Calculate total saturated dissolved concentration when total bile-salt concentrations are \(2.0\), \(5.0\), and \(10.0\) mmol/L. Assume excess solid and use the same \(\beta\) and CMC at each concentration.

At \(2.0\) mmol/L, total bile salt is below the CMC, so \(C_{\mathrm{mic}}=0\). The model predicts \(C_{\mathrm{bound,sat}}=0\) and \(C_{\mathrm{diss,sat}}=0.050\) mg/mL.

At \(5.0\) mmol/L, \(C_{\mathrm{mic}}=5.0-3.0=2.0\) mmol/L \(=0.0020\) mol/L. Thus \(\beta C_{\mathrm{mic}}=(40.0)(0.0020)=0.0800\), and \(C_{\mathrm{bound,sat}}=(0.050)(0.0800)=0.00400\) mg/mL. Total saturated dissolved concentration is \(0.0540\) mg/mL.

At \(10.0\) mmol/L, \(C_{\mathrm{mic}}=7.0\) mmol/L \(=0.0070\) mol/L. The multiplier is \((40.0)(0.0070)=0.280\); hence \(C_{\mathrm{bound,sat}}=(0.050)(0.280)=0.0140\) mg/mL and \(C_{\mathrm{diss,sat}}=0.0640\) mg/mL. The increase is linear in micellized bile-salt concentration in this model, not in total bile-salt concentration across the CMC threshold.

Assumptions, Diagnostics, and Alternatives

The threshold-plus-linear-capacity calculation relies on several assumptions that should be checked before interpreting its output:

Appropriate CMC: The effective CMC represents the bile-salt composition and solution conditions being modeled. A value measured under different conditions may give a misleading \(C_{\mathrm{mic}}\).
Consistent concentration basis: \(C_{\mathrm{BS}}\), \(C_{\mathrm{CMC}}\), and \(C_{\mathrm{mic}}\) have matching units. The units of \(\beta\) match those used for \(C_{\mathrm{mic}}\), so \(\beta C_{\mathrm{mic}}\) has no units.
Linear association: The coefficient \(\beta\), or alternatively \(q\), is treated as constant over the range of interest. Saturation of micellar capacity or changes in aggregate composition can invalidate that approximation.
Drug availability and equilibrium: Saturated capacity applies only if sufficient drug is available and equilibrium is reached. A finite dose can leave the system below capacity.
Free-solubility basis: \(S_0\) refers to free-drug equilibrium solubility under the same relevant aqueous conditions. The model does not justify substituting a total measured concentration for \(S_0\).

A useful diagnostic is the implied fraction of the dissolved pool that is micelle-associated at saturation. The model gives \(C_{\mathrm{bound,sat}}/C_{\mathrm{diss,sat}}=\beta C_{\mathrm{mic}}/(1+\beta C_{\mathrm{mic}})\). If this fraction or the predicted concentration is inconsistent with measured data, first check the CMC, units, and whether the measured assay distinguishes free from total dissolved drug. Also check whether a constant capacity coefficient remains plausible over the tested concentration range.

The simple threshold model is easier to interpret than a smooth empirical relationship that fits total bile-salt concentration directly: it separates the onset of appreciable micellization from the added capacity above that threshold. A measured molar solubilization ratio is a more direct alternative when capacity data are available, whereas \(\beta\) expresses binding relative to free-drug concentration. Both approaches can give the same linear saturated capacity when \(q=\beta S_0\) and all quantities are defined on compatible molar bases. Neither approach, by itself, describes aggregation kinetics or the exchange of drug between micelles and water.

Common Mistakes and Practical Limits

Using total bile salt as micellized bile salt. For example, if total concentration is \(12\) mmol/L and the CMC is \(4\) mmol/L, the threshold model gives \(8\) mmol/L micellized bile salt, not \(12\) mmol/L.
Calling total dissolved concentration free concentration. The prediction \(S_0(1+\beta C_{\mathrm{mic}})\) includes both free and micelle-associated drug. The free concentration at saturation remains \(S_0\) in this model.
Ignoring availability. A calculated capacity is not the amount that must dissolve. If the dose cannot supply that amount, the system cannot reach the saturated capacity.
Applying a single CMC or coefficient universally. These are condition- and drug-dependent inputs, not constants that can be assumed to apply to every bile-salt medium.

The calculation isolates bile-salt micellar capacity; it does not include other solubilizing components or specify how different aggregate types contribute. It also does not predict whether micelle-associated drug can cross an intestinal membrane. Those questions require additional model structure and data. The practical value here is narrower: given a stated CMC and capacity parameter, the model separates the freely dissolved equilibrium concentration from the extra dissolved amount supported by bile-salt micelles.

Key takeaway: Estimate micellized bile salt as the excess above an effective CMC, then calculate the micelle-associated drug pool using a stated capacity relationship. Add that pool to free drug only when reporting total dissolved concentration, and treat the result as an equilibrium capacity subject to drug availability and model assumptions.

Check Your Understanding

Answer each question using the threshold and linear-capacity assumptions stated in this tutorial.

Total bile-salt concentration is \(9.0\) mmol/L and the effective CMC is \(2.5\) mmol/L. What is \(C_{\mathrm{mic}}\)?
If \(C_{\mathrm{mic}}=5.0\) mmol/L, \(S_0=0.030\) mg/mL, and \(\beta=20.0\) L/mol, calculate the micelle-associated and total saturated dissolved drug concentrations.
In one sentence, distinguish free-drug equilibrium solubility from total saturated dissolved concentration in this model.
Why is a calculated saturated capacity not necessarily the amount that will dissolve from a finite dose?
If \(q=0.020\) mol drug per mol micellized bile salt and \(C_{\mathrm{mic}}=6.0\) mmol/L, what is the saturated micelle-associated drug concentration on a molar basis?

Solutions. (1) \(C_{\mathrm{mic}}=9.0-2.5=6.5\) mmol/L. (2) Convert \(5.0\) mmol/L to \(0.0050\) mol/L; \(\beta C_{\mathrm{mic}}=(20.0)(0.0050)=0.100\). Thus \(C_{\mathrm{bound,sat}}=(0.030)(0.100)=0.0030\) mg/mL and \(C_{\mathrm{diss,sat}}=0.030+0.0030=0.033\) mg/mL. (3) Free-drug equilibrium solubility is the free concentration at equilibrium with solid, whereas total saturated dissolved concentration includes both free and micelle-associated drug. (4) The dose may not contain enough drug to fill the predicted dissolved pool, or equilibrium may not be reached. (5) \(C_{\mathrm{bound,sat}}=qC_{\mathrm{mic}}=(0.020)(6.0\ \mathrm{mmol/L})=0.120\) mmol/L.